The changes of serotonin-modulating anticonsolidation protein and dihydropyrimidinase-related protein 2 in the amygdala and blood of depressive rats
PDF

Keywords

depression
male and female rats
indirect ELISA test
amygdala
platelets
SMAP
serotonin-modulating anticonsolidation protein
DRP2
dihydropyrimidinase-related protein 2
anti-SMAP natural autoantibodies

How to Cite

1.
Hasanova LF. The changes of serotonin-modulating anticonsolidation protein and dihydropyrimidinase-related protein 2 in the amygdala and blood of depressive rats. Azerbaijan Journal of Physiology. 2022;37(2):7-12. doi:10.59883/ajp.37

Abstract

Nowadays, depression is referred to psychiatric disease and is widely spread throughout the world. The pathogenesis of depression in humans is characterized by significant disturbances of serotonin turnover and its downregulation in brain structures. The objective of the present study was the definition of the levels of serotonin-modulating anticonsolidation protein (SMAP) and dihydropyrimidinase-related protein 2 (DRP2) in the brain amygdala, platelets, and to anti-SMAP natural autoantibodies in the depression Wistar rats of both sexes. A depression state in the rats was formed in the dominant model and its successful formation was confirmed in the forced swimming test by the decreased timeframe of active swimming. Through the application of an indirect ELISA test in the depressive male and female rats, a downregulation of SMAP and DRP2 in the amygdala, an upregulation of SMAP in the platelets of depressive male rats, a noticeable downregulation of DRP2 in the platelets of depressive female rats, and a sharp downregulation of anti-SMAP natural autoantibodies in the serum of depressive male rats were observed.

https://doi.org/10.59883/ajp.37
PDF

References

Avrameas S. Natural autoantibodies: from “horror autotoxins” to “gnothi seaton”. Immunology Today. 1991;12:154-158.

Collins CM, Kloek J, Elliott JM. Parallel changes in serotonin levels in brain and blood following acute administration of MDMA. J Psychopharmacol. 2013 Jan;27(1):109-12. https://doi.org/10.1177/0269881112463123

Elliott JM, Kent A. Comparison of [125I]iod-lysergic acid diethylamide binding to human frontal cortex and platelet tissue. J Neurochem. 1989;53:191-196.

Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature. 1995 Aug 10;376(6540):509-14. https://doi.org/10.1038/376509a0.

Inagaki N, Chihara K, Arimura N, Ménager C, Kawano Y, Matsuo N, Nishimura T, Amano M, Kaibuchi K. CRMP-2 induces axons in cultured hippocampal neurons. Nat Neurosci. 2001 Aug;4(8):781-2. https://doi.org/10.1038/90476.

Malatynska E, Pinhasov A, Crooke JJ, Smith-Swintosky VL, Brenneman DE. Reduction of dominant or submissive behaviors as models for antimanic or antidepressant drug testing: technical considerations. J Neurosci Methods. 2007 Sep 30;165(2):175-82. https://doi.org/10.1016/j.jneumeth.2007.05.035.

Mekhtiev AA. Revealing in the brain of rats the protein possessing anticonsolidation properties. Bulletin Exper. Biol. Med. 2000;129:147-150.

Poletayev A.B. Regulatory autoantibodies. In book: Monoclonal Antibodies in Neurobiology. Novosibirsk, 1995:37-47.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2022 Azerbaijan Journal of Physiology

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...